LISTI', Angela
 Distribuzione geografica
Continente #
NA - Nord America 2.819
EU - Europa 741
AS - Asia 307
SA - Sud America 4
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.877
Nazione #
US - Stati Uniti d'America 2.811
IT - Italia 356
CN - Cina 169
DE - Germania 102
SG - Singapore 84
GB - Regno Unito 61
IE - Irlanda 52
FI - Finlandia 40
RU - Federazione Russa 35
BE - Belgio 28
FR - Francia 14
IN - India 13
SE - Svezia 13
TR - Turchia 10
RO - Romania 8
CA - Canada 7
IR - Iran 7
JP - Giappone 7
UA - Ucraina 7
ES - Italia 6
DK - Danimarca 4
KR - Corea 4
NL - Olanda 4
BG - Bulgaria 3
CH - Svizzera 3
TW - Taiwan 3
AU - Australia 2
BR - Brasile 2
CI - Costa d'Avorio 2
MO - Macao, regione amministrativa speciale della Cina 2
UZ - Uzbekistan 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
ID - Indonesia 1
IQ - Iraq 1
KW - Kuwait 1
LK - Sri Lanka 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.877
Città #
Fairfield 526
Ashburn 259
Chandler 249
Seattle 244
Woodbridge 220
Wilmington 184
Cambridge 183
Houston 173
Ann Arbor 128
Palermo 95
Singapore 56
Dublin 51
Medford 50
Nanjing 47
Des Moines 35
New York 34
Princeton 32
Altamura 29
Brussels 28
Lawrence 26
Dearborn 23
Ludwigshafen am Rhein 22
San Diego 22
Kitzingen 20
Boardman 19
Shenyang 17
Jinan 16
Beijing 15
Santa Clara 14
London 12
Falls Church 11
Redwood City 11
Bremen 9
Hebei 9
Kumar 9
Tianjin 9
Izmir 8
Tulsa 8
Milan 7
Orange 7
San Paolo di Civitate 7
Tehran 7
Changsha 6
Chicago 6
Helsinki 6
Los Angeles 6
Munich 6
Ningbo 6
Norwalk 6
Phoenix 6
Jiaxing 5
Nanchang 5
Cagliari 4
Edinburgh 4
Frankfurt am Main 4
Napoli 4
Nürnberg 4
Amsterdam 3
Fuzhou 3
Islington 3
Lucera 3
Madrid 3
Monreale 3
Tappahannock 3
Turin 3
Abidjan 2
Aci Sant'antonio 2
Barcelona 2
Bari 2
Duezce 2
Guangzhou 2
Haikou 2
Jacksonville 2
Kunming 2
Lucca 2
Macau 2
Ottawa 2
Padova 2
Parma 2
Pune 2
Rome 2
Saint Petersburg 2
Seoul 2
Siracusa 2
Sofia 2
Taipei 2
Taiyuan 2
Tampa 2
Toronto 2
Venice 2
Washington 2
Zhengzhou 2
Absecon 1
Anoka 1
Aracaju 1
Baghdad 1
Bagheria 1
Belo Horizonte 1
Bologna 1
Buenos Aires 1
Totale 3.095
Nome #
EGFR inhibition in NSCLC: New findings…. and opened questions? 253
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 216
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 199
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 190
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 188
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 169
Nintedanib in NSCLC: Evidence to date and place in therapy 163
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 162
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 159
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 152
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer 143
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 141
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 136
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab 134
The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer 129
Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment 124
Non-coding RNAs functioning in colorectal cancer stem cells 122
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 118
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 117
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 112
Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib 110
Liquid Biopsy in Gynecological Cancers 100
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 89
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 85
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 83
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4) 76
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 73
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 72
null 69
UNRAVELLING THE ROLES OF THE NUCLEAR PROTEIN 1 DURING ER-STRESS INDUCTION 63
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma 62
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 43
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 43
null 25
Totale 4.120
Categoria #
all - tutte 15.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020760 0 0 0 0 113 134 109 88 100 87 102 27
2020/2021639 54 24 38 43 37 48 44 59 65 101 81 45
2021/2022439 27 112 14 17 16 23 26 22 46 33 30 73
2022/2023659 53 120 16 95 67 95 29 69 67 6 29 13
2023/2024273 9 39 18 25 13 62 38 14 0 7 4 44
2024/2025139 8 31 14 57 29 0 0 0 0 0 0 0
Totale 4.120